USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
39.59
+0.07 (0.17%)
Nov 21, 2024, 12:47 PM EST - Market open
USANA Health Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Jan '21 Jan 2, 2021 | Dec '19 Dec 28, 2019 | 2018 - 2014 |
| Revenue | 861.97 | 921.01 | 998.6 | 1,186 | 1,135 | 1,061 | Upgrade
|
| Revenue Growth (YoY) | -7.10% | -7.77% | -15.83% | 4.57% | 6.95% | -10.79% | Upgrade
|
| Cost of Revenue | 164.98 | 176.69 | 193.89 | 217.9 | 209.11 | 187.5 | Upgrade
|
| Gross Profit | 697 | 744.32 | 804.71 | 968.57 | 925.53 | 873.4 | Upgrade
|
| Selling, General & Admin | 614.66 | 651.25 | 697.1 | 798.37 | 749.04 | 727.21 | Upgrade
|
| Operating Expenses | 614.66 | 651.25 | 697.1 | 798.37 | 749.04 | 727.21 | Upgrade
|
| Operating Income | 82.33 | 93.07 | 107.61 | 170.19 | 176.49 | 146.19 | Upgrade
|
| Interest Expense | -0.3 | -0.26 | -0.19 | -0.06 | -0.51 | -0.07 | Upgrade
|
| Interest & Investment Income | 11.49 | 9.64 | 3.79 | 2.52 | 2.54 | 4.71 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.99 | 0.01 | -2.59 | -2.01 | -0.57 | -0.34 | Upgrade
|
| Pretax Income | 92.53 | 102.45 | 108.62 | 170.64 | 177.95 | 150.5 | Upgrade
|
| Income Tax Expense | 38.19 | 38.67 | 39.27 | 54.14 | 53.28 | 49.97 | Upgrade
|
| Net Income | 54.34 | 63.79 | 69.35 | 116.51 | 124.66 | 100.53 | Upgrade
|
| Net Income to Common | 54.34 | 63.79 | 69.35 | 116.51 | 124.66 | 100.53 | Upgrade
|
| Net Income Growth | -9.15% | -8.02% | -40.47% | -6.54% | 24.01% | -20.36% | Upgrade
|
| Shares Outstanding (Basic) | 19 | 19 | 19 | 20 | 21 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 19 | 19 | 19 | 20 | 21 | 23 | Upgrade
|
| Shares Change (YoY) | -0.77% | 0.18% | -5.08% | -4.30% | -6.85% | -7.40% | Upgrade
|
| EPS (Basic) | 2.84 | 3.31 | 3.60 | 5.78 | 5.89 | 4.44 | Upgrade
|
| EPS (Diluted) | 2.83 | 3.30 | 3.59 | 5.73 | 5.86 | 4.41 | Upgrade
|
| EPS Growth | -8.38% | -8.08% | -37.35% | -2.22% | 32.88% | -13.87% | Upgrade
|
| Free Cash Flow | 65.64 | 56.15 | 93.5 | 108.46 | 145.31 | 110.16 | Upgrade
|
| Free Cash Flow Per Share | 3.42 | 2.90 | 4.84 | 5.33 | 6.84 | 4.83 | Upgrade
|
| Gross Margin | 80.86% | 80.82% | 80.58% | 81.63% | 81.57% | 82.33% | Upgrade
|
| Operating Margin | 9.55% | 10.11% | 10.78% | 14.34% | 15.55% | 13.78% | Upgrade
|
| Profit Margin | 6.30% | 6.93% | 6.94% | 9.82% | 10.99% | 9.48% | Upgrade
|
| Free Cash Flow Margin | 7.61% | 6.10% | 9.36% | 9.14% | 12.81% | 10.38% | Upgrade
|
| EBITDA | 95.79 | 105.77 | 121.01 | 183.23 | 190.24 | 160.93 | Upgrade
|
| EBITDA Margin | 11.11% | 11.48% | 12.12% | 15.44% | 16.77% | 15.17% | Upgrade
|
| D&A For EBITDA | 13.45 | 12.7 | 13.39 | 13.04 | 13.75 | 14.74 | Upgrade
|
| EBIT | 82.33 | 93.07 | 107.61 | 170.19 | 176.49 | 146.19 | Upgrade
|
| EBIT Margin | 9.55% | 10.11% | 10.78% | 14.34% | 15.55% | 13.78% | Upgrade
|
| Effective Tax Rate | 41.27% | 37.74% | 36.15% | 31.73% | 29.94% | 33.20% | Upgrade
|
| Advertising Expenses | - | 4.76 | 5.05 | 12.4 | 9.85 | 11.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.